{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:18Z","timestamp":1707523938991},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,22]]},"DOI":"10.7759\/cureus.49250","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T17:04:11Z","timestamp":1700672651000},"source":"Crossref","is-referenced-by-count":0,"title":["The Financial Burden Associated With Conservatively Managed Epistaxis"],"prefix":"10.7759","author":[{"given":"Abubaker","family":"Elamin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laith","family":"Sinan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amena","family":"Al Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24240","article-title":"Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis","volume":"124","author":"Kilty SJ","year":"2014","unstructured":"Kilty SJ, Al-Hajry M, Al-Mutairi D, Bonaparte JP, Duval M, Hwang E, Tse D. Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis. Laryngoscope. 2014, 124:38-42. 10.1002\/lary.24240","journal-title":"Laryngoscope"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-016-0116-8","article-title":"Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management","volume":"45","author":"Chin CJ","year":"2016","unstructured":"Chin CJ, Rotenberg BW, Witterick IJ. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management. J Otolaryngol Head Neck Surg. 2016, 45:3. 10.1186\/s40463-016-0116-8","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13717","article-title":"Dissolvable intranasal haemostatic agents for acute epistaxis: a systematic review and meta-analysis","volume":"46","author":"Milinis K","year":"2021","unstructured":"Milinis K, Swords C, Hardman JC, Slovick A, Hutson K, Kuhn I, Smith ME. Dissolvable intranasal haemostatic agents for acute epistaxis: a systematic review and meta-analysis. Clin Otolaryngol. 2021, 46:485-93. 10.1111\/coa.13717","journal-title":"Clin Otolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2454-5929.ijohns20180724","article-title":"A clinical study of epistaxis","volume":"4","author":"Sampigethya S","year":"2018","unstructured":"Sampigethya S, Cherian E, Pratap D, et al.. A clinical study of epistaxis. Int J Otorhinolaryngol Head Neck Surg. 2018, 4:555. 10.18203\/issn.2454-5929.ijohns20180724","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"ref5","article-title":"Anterior Epistaxis Nasal Pack","author":"Kravchik L","year":"2023","unstructured":"Kravchik L, Hohman MH, Pester JM. Anterior Epistaxis Nasal Pack. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref6","article-title":"Anatomy, Head and Neck, Nasopharynx","author":"Mankowski NL","year":"2023","unstructured":"Mankowski NL, Bordoni B. Anatomy, Head and Neck, Nasopharynx. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref7","article-title":"Anatomy, Head and Neck, Sphenopalatine Foramen","author":"Souza SS","year":"2023","unstructured":"Souza SS, Raggio BS. Anatomy, Head and Neck, Sphenopalatine Foramen. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/wjo2.114","article-title":"Functional nasal surgery in the office-based setting","volume":"9","author":"Mowery AJ","year":"2023","unstructured":"Mowery AJ, Razavi CR. Functional nasal surgery in the office-based setting. World J Otorhinolaryngol Head Neck Surg. 2023, 9:236-41. 10.1002\/wjo2.114","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819890327","article-title":"Clinical practice guideline: nosebleed (epistaxis)","volume":"162","author":"Tunkel DE","year":"2020","unstructured":"Tunkel DE, Anne S, Payne SC, et al.. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020, 162:S1-S38. 10.1177\/0194599819890327","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27767","article-title":"Sphenopalatine artery surgery for refractory idiopathic epistaxis: systematic review and meta-analysis","volume":"129","author":"Kitamura T","year":"2019","unstructured":"Kitamura T, Takenaka Y, Takeda K, et al.. Sphenopalatine artery surgery for refractory idiopathic epistaxis: systematic review and meta-analysis. Laryngoscope. 2019, 129:1731-6. 10.1002\/lary.27767","journal-title":"Laryngoscope"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0003489419826139","article-title":"Bevacizumab as treatment for epistaxis in hereditary hemorrhagic telangiectasia: a literature review","volume":"128","author":"Kini SD","year":"2019","unstructured":"Kini SD, Yiu DW, Weisberg RA, Davila JF, Chelius DC. Bevacizumab as treatment for epistaxis in hereditary hemorrhagic telangiectasia: a literature review. Ann Otol Rhinol Laryngol. 2019, 128:467-71. 10.1177\/0003489419826139","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref12","article-title":"Prevalence of epistaxis among patients receiving otorhinolaryngology services at Muhimbili National Hospital and Muhimbili Orthopedic Institute, Dar es Salaam, Tanzania","volume":"44","author":"Abraham Z","year":"2017","unstructured":"Abraham Z, Chugulu S, Liyombo E, et al.. Prevalence of epistaxis among patients receiving otorhinolaryngology services at Muhimbili National Hospital and Muhimbili Orthopedic Institute, Dar es Salaam, Tanzania. Med J. 2017, 44:184-92.","journal-title":"Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.55668","article-title":"Pattern of epistaxis in Sokoto, Nigeria: a review of 72 cases","volume":"7","author":"Iseh KR","year":"2008","unstructured":"Iseh KR, Muhammad Z. Pattern of epistaxis in Sokoto, Nigeria: a review of 72 cases. Ann Afr Med. 2008, 7:107-11. 10.4103\/1596-3519.55668","journal-title":"Ann Afr Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.29309\/tpmj\/2019.26.11.3914","article-title":"Conservative management, a preferred first line method for treatment of epistaxis","volume":"26","author":"Javed MA","year":"2019","unstructured":"Javed MA. Conservative management, a preferred first line method for treatment of epistaxis. Prof Med J. 2019, 26:1998-2002. 10.29309\/tpmj\/2019.26.11.3914","journal-title":"Prof Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2015\/760","article-title":"Epistaxis - etiological profile and treatment outcome at a tertiary care centre","volume":"4","author":"Shah WA","year":"2015","unstructured":"Shah WA, Amin P, Nazir F. Epistaxis - etiological profile and treatment outcome at a tertiary care centre. J Evol Med Dental Sci. 2015, 4:5204-10. 10.14260\/jemds\/2015\/760","journal-title":"J Evol Med Dental Sci"},{"key":"ref16","unstructured":"Healthcare Expenditure, UK Health Accounts Provisional Estimates. 2022. (2023). Accessed: October 8, 2023: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthcaresystem\/bulletins\/healthcareexpendit...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033367","article-title":"Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England","volume":"10","author":"Guest JF","year":"2020","unstructured":"Guest JF, Keating T, Gould D, Wigglesworth N. Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England. BMJ Open. 2020, 10:e033367. 10.1136\/bmjopen-2019-033367","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2013.5220","article-title":"Recent trends in epistaxis management in the United States: 2008-2010","volume":"139","author":"Villwock JA","year":"2013","unstructured":"Villwock JA, Jones K. Recent trends in epistaxis management in the United States: 2008-2010. JAMA Otolaryngol Head Neck Surg. 2013, 139:1279-84. 10.1001\/jamaoto.2013.5220","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207192-the-financial-burden-associated-with-conservatively-managed-epistaxis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:52Z","timestamp":1707508372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207192-the-financial-burden-associated-with-conservatively-managed-epistaxis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.49250","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}